FMO-1 and FMO-3) oxidize trimethylamine (TMA)
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles
S3-Leitlinie Komplementrmedizin in der Behandlung von onkologischen PatientInnen Langversion Mai 2024, AWMF-Registernummer: 032/055OL Sato S, Namisaki T, Furukawa M, Saikawa S, Kawaratani H, Kaji K, Takaya H, Shimozato N, Sawada Y, Kitagawa K, Moriya K, Akahane T, Mitoro A, Hoki N, Ann T, Yoshiji H
Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (WillisEkbom disease): results from a prospective, multicenter study over 66 weeks
One of the most critical areas of emerging research in these chronic, post-viral illnesses revolves around cellular energy, systemic inflammation, and the body's ability to clear toxic byproducts